Use of High-Dose Hydroxocobalamin for Septic Shock
- PMID: 39864505
- PMCID: PMC12264341
- DOI: 10.1016/j.chest.2025.01.016
Use of High-Dose Hydroxocobalamin for Septic Shock
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: I. D. P. receives funding from NIH and CDC and payments to his institution from Regeneron, Bluejay Diagnostics, and Novartis. None declared (J. R. C., B. L., J. J. P., S. M. B., N. A. B., A. C. L.).
References
-
- Evans L., Rhodes A., Alhazzani W., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. - PubMed
-
- Patel J.J., Venegas-Borsellino C., Willoughby R., Freed J.K. High-dose vitamin B12 in vasodilatory shock: a narrative review. Nutr Clin Pract. 2019;34(4):514–520. - PubMed
-
- Brokmeier H.M., Seelhammer T.G., Nei S.D., Gerberi D.J., Mara K.C., Wittwer E.D., Wieruszewski P.M. Hydroxocobalamin for vasodilatory hypotension in shock: a systematic review with meta-analysis for comparison to methylene blue. J Cardiothorac Vasc Anesth. 2023;37(9):1757–1772. - PubMed
-
- Patel J.J., Willoughby R., Peterson J., et al. High-dose IV hydroxocobalamin (vitamin B12) in septic shock: a double-blind, allocation-concealed, placebo-controlled single-center pilot randomized controlled trial (the Intravenous Hydroxocobalamin in Septic Shock Trial) Chest. 2023;163(2):303–312. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Medical